A股異動 | 勁拓股份(300400.SZ)漲停 與海思簽訂合作備忘錄
格隆匯7月7日丨勁拓股份(300400.SZ)漲停,現報23.23元,封單逾17萬手,暫成交1億元,最新市值56億元。勁拓股份昨日晚間宣佈,公司與深圳市海思半導體有限公司簽訂了《海思勁拓合作備忘錄》,協議簽訂時間為今年7月6日,協議簽訂地點為深圳市。基於勁拓在熱工領域的能力,加之海思大力推進封測產業鏈國產化進程,因此,雙方旨在加大半導體封裝設備領域的合作,解決卡脖子問題,實現產業自主可控。公司表示,該備忘錄的簽訂代表勁拓在熱工領域的能力得到海思認可,雙方建立緊密的戰略合作關係,將推動勁拓快速打造半導體熱工設備研發平台,持續實現半導體產業鏈中系列設備的國產化。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.